Raffaello Pompei
University of Cagliari
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Raffaello Pompei.
Bioorganic & Medicinal Chemistry | 2003
Mariangela Biava; Delia Deidda; Raffaello Pompei; Andrea Tafi; Fabrizio Manetti
During the course of our investigations in the field of azole antimicrobial agents, we have identified BM 212, a pyrrole derivative with good in vitro activity against mycobacteria and candidae. These findings prompted us to prepare new pyrrole derivatives 1-10 in the hope of increasing the activity. The microbiological data showed interesting in vitro activity against Mycobacterium tuberculosis and atypical mycobacteria.
Applied Biochemistry and Biotechnology | 1991
Enrico Sanjust; Raffaello Pompei; Antonio Rescigno; Augusto Rinaldi; Maoro Ballero
Four species ofPleurotus were adapted to grow on olive milling wastewater, and in certain conditions produced high yield of fruit bodies. Some biochemical transformations were observed in the olive milling wastewater owing to the growth ofPleurotus. In particular, the fungi actively excreted large amounts of laccase in the medium, and at the same time the concentration of phenolics and other toxic compounds significantly decreased, as revealed by HPLC analysis and toxicity tests on standard cultures of human cell lines.
Bioorganic & Medicinal Chemistry Letters | 1999
Mariangela Biava; Rossella Fioravanti; Delia Deidda; Carlo Maullu; Raffaello Pompei
During the course of our investigations in the field of azole antimicrobial agents, we have identified BM212 a pyrrole derivative with good in vitro activity against mycobacteria and candidae. These findings prompted us to prepare new pyrrole derivatives 2-6 in the hope of increasing the activity. The microbiological data showed interesting in vitro activity against Mycobacterium tuberculosis and atypical mycobacteria.
Bioorganic & Medicinal Chemistry Letters | 1998
Roberto Di Santo; Roberta Costi; Marino Artico; Silvio Massa; Giorgio Lampis; Delia Deidda; Raffaello Pompei
During development of nitroheterocycles with potential antimycobacterial activities we have tested against Mycobacterium tuberculosis a number of pyrroles strictly related to pyrrolnitrin, an antifungal antibiotic isolated from Streptomyces pyrrocinia. Some of the tested arylpyrrole derivatives and pyrrolnitrin have shown appreciable inhibiting activity against M. tuberculosis and M. avium. SAR studies well correlate antimycobacterial potency with the presence of halogens in the phenyl ring and a nitro group at position 3 of pyrrole.
International Journal of Systematic and Evolutionary Microbiology | 1992
Raffaello Pompei; Francesca Berlutti; Maria Cristina Thaller; Angela Ingianni; Giampiero Cortis; Benedetto Dainelli
Four yellow-pigmented group D enterococci of uncertain taxonomic position were isolated from several humans with severe infections. The results of DNA composition, DNA-DNA hybridization, fatty acid content, and biochemical property studies demonstrated that these organisms were slightly related to other previously described yellow-pigmented enterococcal species and constitute a new species, for which we propose the name Enterococcus flavescens. The type strain of E. flavescens is strain CCM 4239 [corrected].
Cellular and Molecular Life Sciences | 1980
Raffaello Pompei; Alessandra Pani; Ornella Flore; Maria Antonietta Marcialis; B. Loddo
Glycyrrhizic acid inhibits the growth of several DNA and RNA viruses in cell cultures and inactivates Herpes simplex 1 virus irreversibly.
Bioorganic & Medicinal Chemistry | 2008
Caterina Maugeri; Maria Alessandra Alisi; Claudia Apicella; Luciano Cellai; Patrizia Dragone; Elena Fioravanzo; Saverio Florio; Guido Furlotti; Giorgina Mangano; Rosella Ombrato; Renzo Luisi; Raffaello Pompei; Vito Rincicotti; Vincenzo Russo; Marco Vitiello; Nicola Cazzolla
Human Rhinovirus (HRV) is the most important aetiologic agent of common cold in adults and children. HRV is a single-stranded, positive sense RNA virus and, despite the high level of conservation among different serotypes, sequence alignment of viral protease 3C with mammalian protease reveals no homology. Thus, protease 3C is an optimal target for the development of anti-HRV agents. In the present work we investigated the design, the synthesis and the development of new potential reversible inhibitors against HRV protease 3C. Docking studies on the crystallized structure of HRV2 protease 3C led us to the design and the synthesis of a series of 3,5 disubstituted benzamides able to act as analogues of the substrate. We also developed 1,3,5 trisubstituted benzamides where aromatic substitutions on the aryl ring led us to investigate the importance of pi-pi interaction on the stabilization of protease 3C-inhibitor complex. All structures were tested for enzymatic inhibition on HRV14 protease 3C. Results highlighted the inhibitory activity of compounds 13, 14, and 20 (91%, 81%, and 85% at 10 microM, respectively), with the latter exhibiting an ID(50) (dose that inhibits 50% of the viral cytopathic effect) on HRV-14=25 microg/ml.
Flavour and Fragrance Journal | 2001
Graziella Cherchi; Delia Deidda; Barbara De Gioannis; Bruno Marongiu; Raffaello Pompei; Silvia Porcedda
Santolina insularis was used to obtain its essential oil by means of supercritical fluid extraction with carbon dioxide, CO2. The choice of the proper value of CO2 density is the crucial point influencing solvent power and selectivity, the main factors determining oil composition. In circuit to obtain a pure essential oil deprived of cuticular waxes, the extraction products were fractionated in two separators operated in series. A good process performance was obtained working at 90 bar and 50 °C in the extraction vessel, at 90 bar and −12 °C in the first separator and at 20 bar and 15 °C in the second separator. The extraction time proved to be another parameter that determines the composition of the essential oil extracted. Indeed, lower molecular weight and less polar compounds were more readily extracted, since the other families of compounds exhibit higher diffusion times. The oil extracted also contained small quantities of water. The water yield was measured and the possible role of water in the extraction process is discussed. A comparison with the oil obtained by hydrodistillation is also given. Finally, the cytotoxic and antimicrobial activity of the various extracts has been assayed. Copyright
Pharmacological Research | 1994
C. Serra; Giorgio Lampis; Raffaello Pompei; M. Pinza
Twenty-seven triterpenic derivatives of glycyrrhetinic, oleanolic, ursolic and maslinic acid were tested for antiviral and cytotoxic properties. Twelve of them showed apparent antiviral activity against at least one of the tested viruses. The most active compounds were PAS-T45 and 48 which exerted a protection index of 4 on vaccinia virus.
Journal of Applied Microbiology | 1999
Carlo Maullu; Giorgio Lampis; T. Basile; Angela Ingianni; Gian Maria Rossolini; Raffaello Pompei
Cheese whey and cottage cheese whey are by‐products of the milk and cheese industry, resulting from the production of cheese and cottage cheese (ricotta) from milk. They are still rich in organic substances and cannot be discarded into the environment without proper treatment. Whey and cottage cheese whey were used as culture media for some strains of the yeast Kluyveromyces lactis, transformed with the human lysozyme gene. It was found that the yeast strains grew well in both media and produced a considerable amount of recombinant protein. Production kinetics showed that the human lysozyme was produced in a greater amount within 36 h of fermentation (125 μg ml−1vs 25 μg ml−1 in the control) than in the synthetic commercial media used for strain preparation and characterization. The recombinant protein produced was actually shown to be the human lysozyme, using renaturing SDS‐PAGE and Western blot techniques. While producing recombinant protein, the Kluyveromyces strain cleared the cottage cheese whey of most organic substances and produced a considerable amount (almost 3%) of lysozyme‐enriched useful biomass.